Ambeed.cn

首页 / / / / Ceftriaxone sodium hydrate/头孢曲松钠

Ceftriaxone sodium hydrate/头孢曲松钠 {[allProObj[0].p_purity_real_show]}

货号:A487798 同义名: 头孢曲松钠水合物 / Ro 13-9904 sodium hydrate; Ceftriaxone(sodium salt hydrate)

Ceftriaxone sodium hydrate 是一种广谱 β-内酰胺类三代头孢菌素,对革兰氏阴性及阳性菌均具良好抗菌活性;同时是 GSK3β 共价抑制剂(IC50 0.78 μM)和 Aurora B 抑制剂,兼具抗炎、抗肿瘤及抗氧化活性,常用于细菌性感染与脑膜炎的研究。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Ceftriaxone sodium hydrate/头孢曲松钠 化学结构 CAS号:104376-79-6
Ceftriaxone sodium hydrate/头孢曲松钠 化学结构
CAS号:104376-79-6
Ceftriaxone sodium hydrate/头孢曲松钠 3D分子结构
CAS号:104376-79-6
Ceftriaxone sodium hydrate/头孢曲松钠 化学结构 CAS号:104376-79-6
Ceftriaxone sodium hydrate/头孢曲松钠 3D分子结构 CAS号:104376-79-6
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Ceftriaxone sodium hydrate/头孢曲松钠 纯度/质量文件 产品仅供科研

货号:A487798 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Ceftriaxone sodium hydrate/头孢曲松钠 生物活性

描述 Ceftriaxone sodium (trihydrate), one of the beta-lactam antibiotics, is a third-generation semi-synthetic antibiotic belonging to the class of cephalosporins. It has bactericidal action; its main activity is related to the Gram-negative bacteria, being also able to act against Gram-negative bacilli resistant to the first- and second-generation cephalosporins[2]. Ceftriaxone is a stimulator of EAAT2 (Excitatory amino acid transporter2) expression with neuroprotective effects in both in vitro and in vivo models based in part on its ability to inhibit neuronal cell death by glutamate excitotoxicity[3]. Long term ceftriaxone sodium administration resulted in gut microbiota dysbiosis, intestine histological lesions, growth inhibition, spleen index reducing. Not only the immune defense, long term ceftriaxone administration also affected immune regulation[4].

Ceftriaxone sodium hydrate/头孢曲松钠 细胞实验

Cell Line
Concentration Treated Time Description References
THP-1 monocytes 4 mg/L 7 days Evaluated the bactericidal effect of ceftriaxone on intracellular MAC, showing EC50 of 0.20-0.25 times MIC and maximal kill of 1.16-1.96 log10 CFU/mL. J Infect Dis. 2024 Aug 16;230(2):e230-e240.

Ceftriaxone sodium hydrate/头孢曲松钠 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Male Sprague Dawley rats Cocaine self-administration followed by abstinence model Intraperitoneal injection 100 and 200 mg/kg Once daily for 6 days To investigate the effects of ceftriaxone on context-primed relapse following abstinence and its impact on AMPA receptor subunit expression in the NAc. Results showed that both doses of ceftriaxone attenuated relapse and reduced GluA1 expression in the NAc, but did not affect GluA2 expression. Eur Neuropsychopharmacol. 2016 Feb;26(2):186-194
Sprague-Dawley rats 6-hydroxydopamine (6-OHDA) Parkinson’s disease model Intraperitoneal injection 200 mg/kg Seven consecutive daily injections Ceftriaxone increased GLT-1 expression and glutamate uptake, reduced tyrosine hydroxylase (TH) loss induced by 6-OHDA, and decreased amphetamine-induced rotation behavior. Mol Neurobiol. 2014 Jun;49(3):1282-92
Sprague-Dawley rats Subcutaneous injection model Subcutaneous injection 1000 mg/kg Once daily for 12 days To evaluate the local tolerability of subcutaneous ceftriaxone administration. Results showed that the local tissue response was remarkably reduced when the same ceftriaxone dose was given at a lower concentration (25 mg/ml) over a longer period of time (120 min). Antimicrob Agents Chemother. 2020 Feb 21;64(3):e02090-19
Swiss albino mice Cecal ligation and puncture (CLP)-induced sepsis model Subcutaneous injection 100 mg/kg Single dose, 3 hours post-CLP To evaluate the protective effect of ceftriaxone in a sepsis model, results showed that ceftriaxone alone reduced bacterial load but did not significantly improve survival. Inflammation. 2020 Jun;43(3):1035-1043
Mice Tsc1GFAPCKO mouse model Intraperitoneal injection 200 mg/kg Daily until death or the pre-defined endpoint of the experiment Early treatment (before seizure onset) increased astrocyte glutamate transporter expression, decreased extracellular glutamate levels, neuronal death, and seizure frequency, and improved survival; late treatment (after seizure onset) increased glutamate transporter expression but had no effect on seizures. Neurobiol Dis. 2010 Mar;37(3):764-71
Mice Epilepsy model Intraperitoneal injection 200 mg/kg Daily Evaluate the antiepileptic effect of ceftriaxone in epilepsy models J Exp Med. 2017 Feb;214(2):547-563
Mice Pneumococcal meningitis model Intraperitoneal 100 mg/kg Daily starting from 16 hours after infection To evaluate the therapeutic effect of ceftriaxone on pneumococcal meningitis, results showed no significant difference in mortality between the ceftriaxone-treated group and the placebo group. J Neuroinflammation. 2019 Dec 28;16(1):279
BALB/c mice Systemic lupus erythematosus model Oral gavage 400 mg/kg Once daily for 5 consecutive days To reduce pre-existing bacteria populations to boost the proliferation of intestinal microorganisms from donor animals post-FMT Antioxidants (Basel). 2021 Sep 7;10(9):1426
BALB/c mice Vaginal infection model Intraperitoneal 15 mg/kg Single dose To evaluate the therapeutic effect of ceftriaxone on vaginal infection in mice, results showed all mice cleared the infection within 24 hours after treatment. Int J Antimicrob Agents. 2016 Oct;48(4):367-72

Ceftriaxone sodium hydrate/头孢曲松钠 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00002052 HIV Infections ... 展开 >> Salmonella Infections 收起 << Not Applicable Completed - United States, California ... 展开 >> Los Angeles County - USC Med Ctr Los Angeles, California, United States, 90033 收起 <<

Ceftriaxone sodium hydrate/头孢曲松钠 参考文献

[1]Brogden RN, Ward A. Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. Drugs. 1988 Jun;35(6):604-45.

[2]da Trindade MT, Salgado HRN. A Critical Review of Analytical Methods for Determination of Ceftriaxone Sodium. Crit Rev Anal Chem. 2018 Mar 4;48(2):95-101.

[3]Lee SG, Su ZZ, Emdad L, Gupta P, Sarkar D, Borjabad A, Volsky DJ, Fisher PB. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem. 2008 May 9;283(19):13116-23.

[4]Guo Y, Yang X, Qi Y, Wen S, Liu Y, Tang S, Huang R, Tang L. Long-term use of ceftriaxone sodium induced changes in gut microbiota and immune system. Sci Rep. 2017 Feb 21;7:43035.

Ceftriaxone sodium hydrate/头孢曲松钠 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.38mL

0.28mL

0.14mL

6.90mL

1.38mL

0.69mL

13.80mL

2.76mL

1.38mL

Ceftriaxone sodium hydrate/头孢曲松钠 技术信息

CAS号104376-79-6
分子式C18H30N8Na2O14S3
分子量 724.65
SMILES Code CN1C(SCC(CS[C@]2([H])[C@@](/N=C([O-])/C(C3=CSC(N)=N3)=N\OC)([H])C4=O)=C(N42)C([O-])=O)=NC(C(N1)=O)=O.[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[Na+].[Na+]
MDL No. MFCD01750405
别名 头孢曲松钠水合物 ;Ro 13-9904 sodium hydrate; Ceftriaxone(sodium salt hydrate); Rosihlitazone; Ro 13-9904; Ceftriaxone disodium hemiheptahydrate; heptahydrate; Ceftriaxone disodium salt hemi
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Keep in dark place, inert atmosphere, 2-8°C

AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。